SKI Market

Indian Indices

Nifty

25,461.00 55.70
(0.22%)

Sensex

83,432.89 193.42
( 0.23%)

Bank Nifty

57,031.90 239.95
( 0.42%)

Nifty IT

39,166.55 312.25
( 0.80%)

Global Indices

Nasdaq

44,849.54 344.11
(0.77%)

Dow Jones

6,298.76 50.34
(0.81%)

Hang Seng

39,792.23 6.33
(0.02%)

Nikkei 225

8,822.91 -0.29
(0.00%)

Forex

USD-INR

85.63 0.05
(0.05%)

EUR-INR

100.93 0.01
(0.01%)

GBP-INR

117.11 -0.50
(-0.43%)

JPY-INR

0.60 0.00
(-0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

411.1031908

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

57.37

1141.43

EPS(TTM)

Face Value()

Div & Yield %

33.77

Back

garnet international ltd

Ridhi Synthetics standalone net profit declines 10.34% in the December 2024 quarter

Feb 15,2025

Net profit of Ridhi Synthetics declined 10.34% to Rs 0.26 crore in the quarter ended December 2024 as against Rs 0.29 crore during the previous quarter ended December 2023. Sales remain constant at Rs 0.11 crore in the quarter ended December 2024 and also during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	0.11	0.11	0
OPM %	-72.73	-27.27	-
PBDT	0.38	0.40	-5
PBT	0.37	0.40	-8
NP	0.26	0.29	-10

25,461.00 55.70 (0.22%)

83,432.89 193.42 ( 0.23%)

57,031.90 239.95 ( 0.42%)

39,166.55 312.25 ( 0.80%)

44,849.54 344.11 (0.77%)

6,298.76 50.34 (0.81%)

39,792.23 6.33 (0.02%)

8,822.91 -0.29 (0.00%)

85.63 0.05 (0.05%)

100.93 0.01 (0.01%)

117.11 -0.50 (-0.43%)

0.60 0.00 (-0.16%)